Among cancer samples, RSK4 expression was highest in tumours originating from the adrenal gland (PCPG), followed by prostate adenocarcinoma (PRAD) and kidney chromophobe (KICH), while lowest in acute myeloid leukaemia (LAML). Here, RPS6KA6 is linked to acute myeloid leukemia.